Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers

References

• Candan G, Michiue H, Ishikawa S, et al. (2012). Combining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal delivery. Biomaterials 33:6468–75.
   PubMed Web of Science ®Google Scholar
• Cao C, Wang Q, Liu Y. (2019). Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Drug Des Devel Ther 13:1087–98.
   PubMed Web of Science ®Google Scholar
• Chen C, You P. (2017). A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine. Drug Des Devel Ther 11:1941–9.
   PubMed Web of Science ®Google Scholar
• Cohen R, Kanaan H, Grant GJ, Barenholz Y. (2012). Prolonged analgesia from Bupisome and Bupigel formulations: from design and fabrication to improved stability. J Control Release 160:346–52.
   PubMed Web of Science ®Google Scholar
• Danafar H, Davaran S, Rostamizadeh K, et al. (2014). Biodegradable m-PEG/PCL core-shell micelles: preparation and characterization as a sustained release formulation for curcumin. Adv Pharm Bull 4:501–10.
   PubMedGoogle Scholar
• de Araújo DR, da Silva DC, Barbosa RM, et al. (2013). Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches. Expert Opin Drug Deliv 10:1551–63.
   PubMed Web of Science ®Google Scholar
• Franz-Montan M, Ranali J, Ramacciato JC, et al. (2008). Ulceration of gingival mucosa after topical application of EMLA: report of four cases. Br Dent J 204:133–4.
   PubMed Web of Science ®Google Scholar
• Franz-Montan M, Ribeiro LNM, Volpato MC, et al. (2017). Recent advances and perspectives in topical oral anesthesia. Expert Opin Drug Deliv 14:673–84.
   PubMed Web of Science ®Google Scholar
• Grant GJ, Piskoun B, Lin A, Bansinath M. (2000). An in vivo method for the quantitative evaluation of local anesthetics. J Pharmacol Toxicol Methods 43:69–72.
   PubMed Web of Science ®Google Scholar
• Gul R, Ahmed N, Shah KU, Khan GM. (2018). Functionalised nanostructures for transdermal delivery of drug cargos. J Drug Target 26:110–22.
   PubMed Web of Science ®Google Scholar
• Huang X, Huang J, Leng D, et al. (2017). Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells. World J Surg Oncol 15:167.
   PubMed Web of Science ®Google Scholar
• Ito T, Sun L, Bevan MA, Crooks RM. (2004). Comparison of nanoparticle size and electrophoretic mobility measurements using a carbon-nanotube-based coulter counter, dynamic light scattering, transmission electron microscopy, and phase analysis light scattering. Langmuir 20:6940–5.
   PubMed Web of Science ®Google Scholar
• Karande P, Jain A, Ergun K, et al. (2005). Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688–93.
   PubMed Web of Science ®Google Scholar
• Karande P, Jain A, Mitragotri S. (2004). Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 22:192–7.
   PubMed Web of Science ®Google Scholar
• Kumar S, Zakrewsky M, Chen M, et al. (2015). Peptides as skin penetration enhancers: mechanisms of action. J Control Release 199:168–78.
   PubMed Web of Science ®Google Scholar
• Li A, Yang F, Xin J, Bai X. (2019). An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain. Int J Nanomedicine 14:913–20.
   PubMed Web of Science ®Google Scholar
• Loza K, Epple M, Maskos M. (2019). Stability of nanoparticle dispersions and particle agglomeration. In Gehr P, Zellner R, eds. Biological responses to nanoscale particles. NanoScience and technology. Cham (Switzerland): Springer, 85–100.
   Google Scholar
• Mandal B, Mittal NK, Balabathula P, et al. (2016). Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur J Pharm Sci 81:162–71.
   PubMed Web of Science ®Google Scholar
• Mathew TV, Kuriakose S. (2013). 4-(1-Pyrenyl)butyric acid-functionalised chitosan as a matrix for AgNP: photoresponsive and thermal properties. J Polym Res 20:1–8.
   Web of Science ®Google Scholar
• Mueller J, Oliveira JSL, Barker R, et al. (2016). The effect of urea and taurine as hydrophilic penetration enhancers on stratum corneum lipid models. Biochim Biophys Acta 1858:2006–18.
   PubMed Web of Science ®Google Scholar
• Müller RH, Shegokar R, Keck CM. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol 8:207–27.
   PubMedGoogle Scholar
• Münch S, Wohlrab J, Neubert RHH. (2017). Dermal and transdermal delivery of pharmaceutically relevant macromolecules. Eur J Pharm Biopharm 119:235–42.
   PubMed Web of Science ®Google Scholar
• Nagahara H, Vocero-Akbani AM, Snyder EL, et al. (1998). Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4:1449–52.
   PubMed Web of Science ®Google Scholar
• Nasrollahi SA, Taghibiglou C, Azizi E, Farboud ES. (2012). Cell-penetrating peptides as a novel transdermal drug delivery system. Chem Biol Drug Des 80:639–46.
   PubMed Web of Science ®Google Scholar
• Ookubo N, Michiue H, Kitamatsu M, et al. (2014). The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine. Biomaterials 35:4508–16.
   PubMed Web of Science ®Google Scholar
• Patlolla RR, Desai PR, Belay K, Singh MS. (2010). Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials 31:5598–607.
   PubMed Web of Science ®Google Scholar
• Pham QD, Björklund S, Engblom J, et al. (2016). Chemical penetration enhancers in stratum corneum - relation between molecular effects and barrier function. J Control Release 232:175–87.
   PubMed Web of Science ®Google Scholar
• Pino CJ, Scherer MA, Shastri VP. (2014). Investigation of the transdermal transport of charged local anesthetics in the presence of triterpene saponin glycosides. Drug Deliv Transl Res 4:131–8.
   PubMed Web of Science ®Google Scholar
• Song Y, Cai H, Yin T, et al. (2018). Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Int J Nanomedicine 13:1585–600.
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Kosuge M, Tadokoro A, et al. (2006). Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate. ACS Chem Biol 1:299–303.
   PubMed Web of Science ®Google Scholar
• Vitorino C, Almeida J, Gonçalves LM, et al. (2013). Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. J Control Release 167:301–14.
   PubMed Web of Science ®Google Scholar
• Wang Y, Su W, Li Q, et al. (2013). Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery. Int J Pharm 441:748–56.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Shi P. (2016). Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Drug Deliv 23:3193–9.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev 56:603–18.
   PubMed Web of Science ®Google Scholar
• You P, Yuan R, Chen C. (2017). Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers. Drug Des Devel Ther 11:2743–52.
   PubMed Web of Science ®Google Scholar
• Yue Y, Zhao D, Yin Q. (2018). Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: in vitro and in vivo anesthesia evaluation. Biomed Pharmacother 98:813–20.
   PubMed Web of Science ®Google Scholar
• Zhang C, Peng F, Liu W, et al. (2014). Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Int J Nanomedicine 9:1049–63.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yue Y, Chang M. (2017). Local anaesthetic pain relief therapy: in vitro and in vivo evaluation of a nanotechnological formulation co-loaded with ropivacaine and dexamethasone. Biomed Pharmacother 96:443–9.
   PubMed Web of Science ®Google Scholar
• Zhao X, Sun Y, Li Z. (2018). Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system. Drug Des Devel Ther 12:4231–40.
   PubMed Web of Science ®Google Scholar